Jalali, A.; Miresse, D.; Fahey, M.R.; Ni Mhaonaigh, N.; McGuire, A.; Bourke, E.; Kerin, M.J.; Brown, J.A.L.
Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort. Curr. Oncol. 2022, 29, 7512-7523.
https://doi.org/10.3390/curroncol29100591
AMA Style
Jalali A, Miresse D, Fahey MR, Ni Mhaonaigh N, McGuire A, Bourke E, Kerin MJ, Brown JAL.
Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort. Current Oncology. 2022; 29(10):7512-7523.
https://doi.org/10.3390/curroncol29100591
Chicago/Turabian Style
Jalali, Amirhossein, David Miresse, Matthew R. Fahey, Niamh Ni Mhaonaigh, Andrew McGuire, Emer Bourke, Michael J. Kerin, and James A. L. Brown.
2022. "Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort" Current Oncology 29, no. 10: 7512-7523.
https://doi.org/10.3390/curroncol29100591
APA Style
Jalali, A., Miresse, D., Fahey, M. R., Ni Mhaonaigh, N., McGuire, A., Bourke, E., Kerin, M. J., & Brown, J. A. L.
(2022). Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort. Current Oncology, 29(10), 7512-7523.
https://doi.org/10.3390/curroncol29100591